NCT07425327

Brief Summary

The aim of our study was to evaluate the psychometric properties of the 2-minute step test in hemophilia patients, assess its intra-rater and inter-rater reliability, and evaluate its convergent validity and construct validity supported by measurements of gait, balance, and functionality.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
0mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Feb 2026Jun 2026

First Submitted

Initial submission to the registry

February 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

February 25, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2026

Expected
Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

February 13, 2026

Last Update Submit

February 13, 2026

Conditions

Keywords

Hemophilia AHemophilia BTwo minute step test

Outcome Measures

Primary Outcomes (1)

  • 2-Minute Step Test

    The 2MST is widely used to assess aerobic endurance and physical fitness. In this study, the 2MST protocol developed by Rikli and Jones will be used. Before the test, the midpoint between the anterior superior iliac spine and the top of the patella will be measured for each participant, and the target height for knee elevation will be marked on the wall with adhesive tape for standardization. Upon hearing the verbal cue "Go," participants will begin walking (not running) in place and will lift each knee to reach the target height. The test will be timed with a stopwatch, and the number of steps will be recorded directly by observation by a physical therapist.

    through of the study, average 4 months

Secondary Outcomes (3)

  • 2-Minute Walk Test (2MWT):

    through of the study, average 4 months

  • Timed Up and Go Test (TUG):

    through of the study, average 4 months

  • One-Legged Standing Test:

    through of the study, average 4 months

Study Arms (1)

Hemophilia Group

The sample population consists of hemophilia patients aged 6-18 years who are receiving outpatient treatment, who voluntarily participate in the study and who meet the inclusion criteria. An appropriate sampling method will be used in the selection of the sample.

Eligibility Criteria

Age6 Years - 18 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsHemophilia X is a genetically inherited disease, so women are carriers. Symptoms are observed in males.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The sample population consists of hemophilia patients aged 6-18 who are receiving outpatient treatment, who voluntarily participate in the study and meet the inclusion criteria. An appropriate sampling method will be used in the sample selection.

You may qualify if:

  • Diagnosed with Hemophilia (A-B) by a physician,
  • Aged 6-18 years,
  • Receiving regular prophylactic treatment,
  • Inhibitor positive or negative,
  • No history of lower extremity joint bleeding within the last month,
  • Individuals who are willing to participate in the study,

You may not qualify if:

  • Patients who have undergone surgery on the lower extremities for any reason within the last 6 months,
  • Patients with neurological sequelae following a history of intracranial hemorrhage,
  • Patients experiencing cognitive impairment to the extent that they cannot understand the tests,
  • Patients who indicate they will be unable to participate in follow-up measurements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasan Kalyoncu University

Gaziantep, Şahinbey, (505) 090-5846, Turkey (Türkiye)

Location

Related Publications (5)

  • Nogueira MA, Almeida TDN, Andrade GS, Ribeiro AS, Rego AS, Dias RDS, Ferreira PR, Penha LRLN, Pires FO, Dibai-Filho AV, Bassi-Dibai D. Reliability and Accuracy of 2-Minute Step Test in Active and Sedentary Lean Adults. J Manipulative Physiol Ther. 2021 Feb;44(2):120-127. doi: 10.1016/j.jmpt.2020.07.013. Epub 2021 Jan 9.

  • Cederberg KLJ, Sikes EM, Bartolucci AA, Motl RW. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance. Gait Posture. 2019 Sep;73:147-153. doi: 10.1016/j.gaitpost.2019.07.125. Epub 2019 Jul 10.

  • Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.

  • Eriksen L, Curtis T, Gronbaek M, Helge JW, Tolstrup JS. The association between physical activity, cardiorespiratory fitness and self-rated health. Prev Med. 2013 Dec;57(6):900-2. doi: 10.1016/j.ypmed.2013.09.024. Epub 2013 Oct 5.

  • Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, Carcao M, Mahlangu J, Ragni MV, Windyga J, Llinas A, Goddard NJ, Mohan R, Poonnoose PM, Feldman BM, Lewis SZ, van den Berg HM, Pierce GF; WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3. No abstract available.

MeSH Terms

Conditions

Hemophilia AHemophilia B

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, X-Linked

Study Officials

  • Tuğba GÖNEN, Asisst. Prof. Dr.

    Hasan Kalyoncu University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tuğba GÖNEN, Asisst. Prof. Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asisst. Prof. Dr.

Study Record Dates

First Submitted

February 13, 2026

First Posted

February 20, 2026

Study Start

February 25, 2026

Primary Completion

April 25, 2026

Study Completion (Estimated)

June 25, 2026

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations